iobenguane I-131 15 MCI/ML [Azedra]

RxNorm concept 2053288, branded drug component (sbdc).

RxCUI: 2053288
Term type: Branded drug component (SBDC)
Status: Active

Request

curl https://api.healthcare.dev/v1/drugs/rxnorm/2053288 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Concept

Ingredients and related concepts

Ingredients

3-iodobenzylguanidine 14448

Related concepts

2 ML iobenguane I-131 15 MCI/ML Injection [Azedra] (SBD, constitutes)
22.5 ML iobenguane I-131 15 MCI/ML Injection [Azedra] (SBD, constitutes)
Azedra (BN, has ingredient)
iobenguane I-131 15 MCI/ML (SCDC, tradename of)

Linked data

NDCs

RxNorm links no NDCs to this concept.

Use it

Look up 2053288 from code or an agent

curl

curl https://api.healthcare.dev/v1/drugs/rxnorm/2053288 \
  -H "Authorization: Bearer $HDEV_API_KEY"

MCP prompt

Using the healthcare.dev MCP server, look up RxNorm concept 2053288. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.

Get a free key RxNorm docs Connect the MCP server

Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.